Literature DB >> 2998652

I-cell disease: clinical studies of 21 Japanese cases.

S Okada, M Owada, T Sakiyama, T Yutaka, M Ogawa.   

Abstract

Clinical pictures of 21 cases with I-cell disease patients, 12 males and 9 females, were analyzed. Characteristic coarse facial features and shortness of stature were observed in all cases. In general, the motor development was found to be more severely retarded than the mental development of the patients. Rather little involvement of the nervous system seemed to cause somewhat acceptable mental development in some cases, and also cause the absence of epileptic seizures in all cases. Involvement of the cardiovascular system, especially progressive hypertrophic cardiomyopathy, could be highly responsible for frequent sudden death of I-cell disease patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998652     DOI: 10.1111/j.1399-0004.1985.tb00388.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

1.  I-cell disease complicated by unusual dilatative cardiomyopathy.

Authors:  P Müller; H Reichenbach; A Möckel; P Bührdel
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

2.  I-cell disease (Mucolipidosis II).

Authors:  M Kabra; S Gulati; M Kaur; J Sharma; A Singh; V Chopra; P S Menon; V Kalra
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 1.967

3.  The natural history and osteodystrophy of mucolipidosis types II and III.

Authors:  Grace David-Vizcarra; Julie Briody; Jenny Ault; Michael Fietz; Janice Fletcher; Ravi Savarirayan; Meredith Wilson; Jim McGill; Matthew Edwards; Craig Munns; Melanie Alcausin; Sara Cathey; David Sillence
Journal:  J Paediatr Child Health       Date:  2010-03-29       Impact factor: 1.954

4.  Clinical Characterization of Mucolipidoses II and III: A Multicenter Study.

Authors:  Taciane Alegra; Fernanda Sperb-Ludwig; Nicole Ruas Guarany; Erlane M Ribeiro; Charles M Lourenço; Chong Ae Kim; Eugênia R Valadares; Marcial Francis Galera; Angelina X Acosta; Dafne Dain Gandelman Horovitz; Ida Vanessa Doederlein Schwartz
Journal:  J Pediatr Genet       Date:  2019-09-24

Review 5.  Screening for lysosomal disorders.

Authors:  K Ullrich
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

Review 6.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

7.  Mucolipidosis II presenting as severe neonatal hyperparathyroidism.

Authors:  Sheila Unger; David A Paul; Michelle C Nino; Charles P McKay; Stephen Miller; Etienne Sochett; Nancy Braverman; Joe T R Clarke; David E C Cole; Andrea Superti-Furga
Journal:  Eur J Pediatr       Date:  2004-12-03       Impact factor: 3.183

8.  Outcomes after hematopoietic stem cell transplantation for children with I-cell disease.

Authors:  Troy C Lund; Sara S Cathey; Weston P Miller; Mary Eapen; Martin Andreansky; Christopher C Dvorak; Jeffrey H Davis; Jignesh D Dalal; Steven M Devine; Gretchen M Eames; William S Ferguson; Roger H Giller; Wensheng He; Joanne Kurtzberg; Robert Krance; Emmanuel Katsanis; Victor A Lewis; Indira Sahdev; Paul J Orchard
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-10       Impact factor: 5.742

9.  Severe dilated cardiomyopathy as an unusual finding in a young infant with mucolipidosis type 2.

Authors:  P Mueller; A Moeckel; I Daehnert
Journal:  Images Paediatr Cardiol       Date:  2006-10

10.  A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth.

Authors:  Ju Sun Heo; Ka Young Choi; Se Hyoung Sohn; Curie Kim; Yoon Joo Kim; Seung Han Shin; Jae Myung Lee; Juyoung Lee; Jin A Sohn; Byung Chan Lim; Jin A Lee; Chang Won Choi; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  Korean J Pediatr       Date:  2012-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.